Calcium, vascular smooth muscle, and calcium entry blockers in hypertension

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Increases in vascular tone induced by an increase in cytosol calcium concentration may be important in the development of hypertension, myocardial ischemia, and other cardiovascular disorders. A heterogeneous group of compounds known as calcium entry blockers inhibit smooth muscle contraction induced by physiologic and pharmacologic stimuli blocking transmembrane transport of calcium through membrane channels. These drugs may reduce blood pressure through effects on the heart, the venous capacitance vessels, the arterial resistance vessels, and the renin-angiotensin system. Although their efficacy in antihypertensive therapy may eventually prove to be nonspecific, their ability to interfere with a basic cellular mechanism for vasoconstriction makes these drugs attractive as potential specific treatment for the abnormal vasomotion in patients with hypertension.

Original languageEnglish (US)
Pages (from-to)806-809
Number of pages4
JournalAnnals of internal medicine
Volume98
Issue number5 Suppl.
StatePublished - Jan 1 1983

Fingerprint

Vascular Smooth Muscle
Hypertension
Calcium
Renin-Angiotensin System
Muscle Contraction
Vasoconstriction
Ion Channels
Pharmaceutical Preparations
Cytosol
Antihypertensive Agents
Myocardial Ischemia
Smooth Muscle
Blood Vessels
Blood Pressure
Therapeutics

Cite this

Calcium, vascular smooth muscle, and calcium entry blockers in hypertension. / Cohn, Jay N.

In: Annals of internal medicine, Vol. 98, No. 5 Suppl., 01.01.1983, p. 806-809.

Research output: Contribution to journalArticle

@article{a9dbe1f01ef2498db42cab0e925317b2,
title = "Calcium, vascular smooth muscle, and calcium entry blockers in hypertension",
abstract = "Increases in vascular tone induced by an increase in cytosol calcium concentration may be important in the development of hypertension, myocardial ischemia, and other cardiovascular disorders. A heterogeneous group of compounds known as calcium entry blockers inhibit smooth muscle contraction induced by physiologic and pharmacologic stimuli blocking transmembrane transport of calcium through membrane channels. These drugs may reduce blood pressure through effects on the heart, the venous capacitance vessels, the arterial resistance vessels, and the renin-angiotensin system. Although their efficacy in antihypertensive therapy may eventually prove to be nonspecific, their ability to interfere with a basic cellular mechanism for vasoconstriction makes these drugs attractive as potential specific treatment for the abnormal vasomotion in patients with hypertension.",
author = "Cohn, {Jay N}",
year = "1983",
month = "1",
day = "1",
language = "English (US)",
volume = "98",
pages = "806--809",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5 Suppl.",

}

TY - JOUR

T1 - Calcium, vascular smooth muscle, and calcium entry blockers in hypertension

AU - Cohn, Jay N

PY - 1983/1/1

Y1 - 1983/1/1

N2 - Increases in vascular tone induced by an increase in cytosol calcium concentration may be important in the development of hypertension, myocardial ischemia, and other cardiovascular disorders. A heterogeneous group of compounds known as calcium entry blockers inhibit smooth muscle contraction induced by physiologic and pharmacologic stimuli blocking transmembrane transport of calcium through membrane channels. These drugs may reduce blood pressure through effects on the heart, the venous capacitance vessels, the arterial resistance vessels, and the renin-angiotensin system. Although their efficacy in antihypertensive therapy may eventually prove to be nonspecific, their ability to interfere with a basic cellular mechanism for vasoconstriction makes these drugs attractive as potential specific treatment for the abnormal vasomotion in patients with hypertension.

AB - Increases in vascular tone induced by an increase in cytosol calcium concentration may be important in the development of hypertension, myocardial ischemia, and other cardiovascular disorders. A heterogeneous group of compounds known as calcium entry blockers inhibit smooth muscle contraction induced by physiologic and pharmacologic stimuli blocking transmembrane transport of calcium through membrane channels. These drugs may reduce blood pressure through effects on the heart, the venous capacitance vessels, the arterial resistance vessels, and the renin-angiotensin system. Although their efficacy in antihypertensive therapy may eventually prove to be nonspecific, their ability to interfere with a basic cellular mechanism for vasoconstriction makes these drugs attractive as potential specific treatment for the abnormal vasomotion in patients with hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0020586333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020586333&partnerID=8YFLogxK

M3 - Article

C2 - 6847019

AN - SCOPUS:0020586333

VL - 98

SP - 806

EP - 809

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5 Suppl.

ER -